Business Segments Interpace Biosciences, Inc.
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.525 USD | -1.61% |
|
-7.01% | +23.96% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Laboratory Services | ||||||||||
Developing and Selling Clinical and Pharma Services | 41.31M | 31.84M | 40.21M | 46.93M | 38.73M | |||||
Total Assets | 38.43M | 15.98M | 13.02M | 14.79M | 33.84M | |||||
Interest Expense | -920K | -1.01M | -1.01M | -659K | -168K | |||||
Income Tax Expense | -667K | 29K | 17K | 4K | -21.21M | |||||
CAPEX | -354K | -322K | -470K | -876K | -356K | |||||
EBT | -15.41M | -5.84M | 1.13M | 6.95M | 3.77M | |||||
Gross Profit | 17.94M | 18.23M | 23.9M | 29.92M | 24.13M | |||||
D&A | 5.07M | 2.56M | 1.6M | 748K | 821K | |||||
Operating Income | -14M | -3.62M | 2.8M | 8.11M | 4.08M | |||||
Net Income | -14.94M | -21.96M | 802K | 6.7M | 24.58M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 41.31M | 31.84M | 40.21M | 46.93M | 38.73M | |||||
Total Assets | 38.43M | 15.98M | 13.02M | 14.79M | 33.84M | |||||
Interest Expense | -920K | -1.01M | -1.01M | -659K | -168K | |||||
Income Tax Expense | -667K | 29K | 17K | 4K | -21.21M | |||||
D&A | 5.07M | 2.56M | 1.6M | 748K | 821K | |||||
CAPEX | -354K | -322K | -470K | -876K | -356K | |||||
Gross Profit | 17.94M | 18.23M | 23.9M | 29.92M | 24.13M | |||||
Net Income | -14.94M | -21.96M | 802K | 6.7M | 24.58M | |||||
EBT | -15.41M | -5.84M | 1.13M | 6.95M | 3.77M | |||||
Operating Income | -14M | -3.62M | 2.8M | 8.11M | 4.08M |
- Stock Market
- Stocks
- IDXG Stock
- Financials Interpace Biosciences, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
